However, like any medication, its important to use it under the supervision of a healthcare provider to ensure its appropriate for your specific health needs
An oral version of these drugswhich are known as glucagon-like peptide 1 (GLP-1) receptor agonistscould be more accessible and would come without the inconvenience, pain or medical waste of shots
Innovations, such as oral formulations and dual-target agonists, are reshaping competitive positioning
Persistent deficiencies may contribute to fatigue, weakness, anemia, and reduced treatment tolerance
Atherosclerosis GLP-1RAs may exert anti-atherogenic effects, as CVOTs show reduced MACE after 1218 months, particularly in patients with established CV disease